MNKD FY 2025 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$813M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$349M+22.2% YoY

Gross Profit

$288M82.5% margin

Operating Income

$39M11.1% margin

Net Income

$6M1.7% margin

EPS (Diluted)

$0.02

Cash Flow

Operating Cash Flow

$18M

Free Cash Flow

$14M

Stock-Based Comp.

$24M

Balance Sheet

Total Assets

$792M

Total Liabilities

$843M

Stockholders' Equity

-$51M

Cash & Equivalents

$75M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$349M	$286M	+22.2%
Gross Profit	$288M	$209M	+37.8%
Operating Income	$39M	$73M	-46.5%
Net Income	$6M	$28M	-78.7%